Here we describe the identification of novel cell migration-promoting genes based on an unbiased functional genetic screen in cultured cells. After the introduction of the retroviral mouse brain cDNA library into NIH3T3 mouse fibroblast cells, migration-promoted cells were selected by a 3-dimensional migration assay using cell culture inserts. After 5 rounds of enrichment, cDNAs were retrieved from the cells with a selected phenotype. Cell migration-promoting activity was confirmed by independent migration assays for the retrieved cDNAs, among which further investigation was focused on coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (chchd2). Whereas overexpression of chchd2 promoted cell migration, knockdown of endogenous chchd2 expression reduced cell migration. Chchd2-induced cell migration was associated with augmented formation of actin stress fibers and focal adhesion, which was mediated through Akt, RhoA/ROCK, and Jnk pathways. 
Cell migration is a vital process that is required for embryonic development, wound repair, inflammatory response, and tumor metastasis (1) (2) (3) . Cell migration is considered to be a complex and highly coordinated process that involves the formation of extended protrusions in the direction of migration, and it is driven by actin cytoskeleton and focal adhesion (4) . Cell migration is believed to be under the control of complex regulatory mechanisms that are likely to be mediated by numerous genes. To identify novel genes that regulate the process of cell migration, we used an in vitro screen based on functional selection of a cell migration phenotype after introduction of a retroviral cDNA library.
Gain of function in vitro selections are powerful tools that have been used for the identification of cDNAs having phenotypes of interest (5) (6) (7) (8) (9) . In early studies, plasmid libraries were introduced into suitable and easily transfectable selector cells followed by screening for a transiently appearing phenotype (10) . Compared with the plasmid-based strategy, the retroviral vector exhibits a large cloning capacity and enables long-term expression of desired transgenes after integration into the target chromosomes. In particular, pseudotyping of transgenic retroviral particles extends their tropism and increases their transduction efficiency (11, 12) . Previously, retrovirus-based selections were useful tools for the identification of genes associated with specific phenotypes in vitro as well as in vivo (5) (6) (7) (8) . For instance, novel metastasispromoting genes were recently isolated by an in vivo selection system using retroviral cDNA libraries (13) .
Here, we describe the identification of novel cell migration-promoting genes by combining gain-of-function selection of a retroviral cDNA library with an in vitro selection for cell migration. The unbiased selection procedure successfully identified multiple migration-promoting genes. One of the genes identified in the current study was a coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (chchd2). Further investigation into the molecular mechanisms underlying chchd2-promoted cell migration revealed that Akt, RhoA/RhoA kinase (ROCK), and c-Jun NH 2 -terminal kinase (Jnk) pathways play a central role in CHCHD2 actions, which may be fine-tuned by the binding partner of CHCHD2, hyaluronic acid (HA)-binding protein 1 (HABP1).
Calbiochem (La Jolla, CA, USA). A specific Rho inhibitor, C3 transferase, was obtained from Cytoskeleton, Inc. (Denver, CO, USA). Antibodies against green fluorescence protein (GFP), c-Myc tag, and FLAG tag were obtained from Cell Signaling Technology (Danvers, MA, USA). An actin cytoskeleton and focal adhesion staining kit containing vinculin antibody and tetramethylrhodamine isothiocyanate (TRITC)-conjugated phalloidin was obtained from Millipore (Billerica, MA, USA). Fluorescein isothiocyanate (FITC)-conjugated secondary antibody (anti-mouse IgG) and Cy5-conjugated secondary antibody (anti-rabbit IgG) were obtained from BD Biosciences Pharmingen (San Diego, CA, USA). Phoenix Eco cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS (Lonza Walkersville, Walkersville, MD, USA), hygromycin B (300 g/ml), and diphtheria toxin (1 g/ml) at 37°C and 5% CO 2 . NIH3T3 mouse fibroblast cells and HEK293 human epithelial cells were cultured in DMEM containing 10% FBS, penicillin (10 U/ml), and streptomycin (10 g/ml) at 37°C and 5% CO 2 . All cell lines were obtained from American Type Culture Collection (Manassas, VA, USA).
Retrovirus production and infection
A retroviral cDNA library was generated by transient transfection of Phoenix Eco packaging cells (14) with the ViraPort XR Mouse Brain cDNA Library (Stratagene; La Jolla, CA, USA) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer's instructions. Cell-free supernatants were harvested 2-3 d after transfection and subsequently were used to transduce NIH3T3 fibroblast cells in the presence of 8 g/ml Polybrene. After 24 h, the virus-containing supernatant was removed by centrifugation. To optimize conditions of viral infection and to monitor virus titer, a test construct of the retroviral vector carrying GFP (pFB-hrGFP) (Stratagene) was used. For infection of NIH3T3 fibroblast cells, cells (1ϫ10 5 cells/well) were seeded onto 60-mm culture plates 18 h before infection and incubated with 1 ml of virus stock for 6 -8 h in the presence of Polybrene (8 g/ml). Then, 2 ml of fresh DMEM/10% FBS containing Polybrene (8 g/ml) was added to the culture and the incubation was continued. After another 24 h, cells were removed from the plates, and infection efficiency and viral titer were determined by the detection of GFP using fluorescence-activated cell sorting or RT-PCR with ⌿ signal-specific primers (⌿ is the signal sequence for the initiation of virus packaging). The titer of the viral cDNA library was ϳ1.2 ϫ 10 6 plaque-forming units/ml (Supplemental Fig. S1 ). NIH3T3 fibroblast cells were infected with the retroviral library of mouse brain cDNAs at multiplicity of infection (MOI) of 1.
Screening procedure
NIH3T3 fibroblast cells (1ϫ10 5 cells/ml) were infected with the retroviral cDNA library at MOI of 1 in the presence of Polybrene (8 g/ml). Two days after infection, the cells were detached and seeded (4ϫ10 4 cells/well) onto the transwell culture inserts (8-m pore membrane; Millipore) and incubated at 37°C for 5 h. Migrated cells were collected by trypsinization of the cells adhered to the lower face of the transwell culture inserts and reseeded onto the transwell culture inserts. Cells were then allowed to migrate again for enrichment, which was repeated 5 times. After the final round of enrichment, migrated cells were expanded into individual clones by limiting dilution. To determine the sequences of the chromosomally integrated cDNAs, a small amount (50 ng) of genomic DNA isolated from each clone was subjected to PCR. The cDNA segments were amplified by using Retro primers (included in the ViraPort XR Mouse Brain cDNA Library) that are specific for regions flanking the multiple cloning site of the pFB retroviral vector (backbone of the ViraPort XR Mouse Brain cDNA Library). The Retro primer sequences were Retro forward, GGCTGCCGACCCCGGGGGTGG, and Retro reverse, CGAACCCCAGAGTCCCGCTCA. The resulting PCR fragments were purified and sequenced, and then identified cDNAs were cloned into pcDNA3 for further analysis.
Construction of plasmids
For the evaluation of migration-promoting activity of cDNAs identified from functional selection, cDNAs were cloned into pcDNA3. In brief, cDNAs containing EcoRI and XhoI sites were amplified by using Retro primers. The amplified PCR products were digested with EcoRI and XhoI and cloned into the EcoRI and XhoI sites of pcDNA3 (Supplemental Fig. S2A ). For the investigation of intracellular localization of CHCHD2, GFP-fused wild-type or mutated chchd2 expression plasmids were generated. For the coimmunoprecipitation experiment, Myc-tagged chchd2 or FLAG-tagged HABP1 was constructed. Detailed information on the plasmid construction can be found in Supplemental Fig. S2B .
Transient or stable transfection
The transient or stable transfection of NIH3T3 fibroblast cells or HEK293 epithelial cells with constructed plasmids was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Two days after the transfection, transiently transfected cells were used for the experiments. Stably transfected cells were selected in the presence of 0.5 mg/ml G418 (Calbiochem, San Diego, CA, USA) for 3 wk. G418 was added at 2 d after the transfection.
Wound-healing assay
For wound-healing migration assays, cells were seeded onto 6-well plates at a density of 2 ϫ 10 5 cells/well. Twelve hours after seeding, confluent cells were scratched with a fine pipette tip and washed with PBS. Photographs were taken after incubation for 0, 12, 24, and 48 h. Relative cell migration distance was determined by measuring the wound width on the monolayer under a microscope (Olympus CK2; ϫ100; Olympus, Tokyo, Japan) and by subtracting this from the initial value as described previously: cell migration distance ϭ initial wound width at 0 h Ϫ wound width at the time of measurement (15) . The data acquired from the three scratches on each plate were converted to the percentage of wound closure at a given time. The results are presented as the percentage of wound closure as follows: percentage of wound closure ϭ (cell migration distance at the time of measurement/initial wound width) ϫ 100.
Three-dimensional cell migration assay
Cell migration was determined by using the transwell culture inserts (8-m pore membrane; Millipore) according to the manufacturer's instructions. In brief, cells (4ϫ10 4 cells/well) were seeded onto the upper chamber and allowed to migrate toward the lower face of the transwell culture inserts. Cells were incubated at 37°C for 5 h. Nonmigrating cells on the inner side of the transwell culture inserts were removed with a cotton swab. Migrated cells on the underside of the inserts were fixed with methanol for 10 min and stained with Mayer's hematoxylin (DakoCytomation, Glostrup, Denmark) for 20 min. Photomicrographs of 5 random fields were taken (Olympus CK2; ϫ100), and cells were enumerated to calculate the average number of cells that had migrated. All migrated cells were counted, and the results are presented as an increase compared with the control.
Western blot analysis
Cells were lysed in triple-detergent lysis buffer, and the protein concentration of cell lysates was determined using a Quant-iT Protein Assay kit (Invitrogen) after centrifugation for 20 min at 4°C. The samples were boiled for 5 min, subjected to SDS-polyacrylamide gel electrophoresis (10% gel), and transferred to Hybond ECL nitrocellulose membranes (Amersham Biosciences; Piscataway, NJ, USA). The membranes were sequentially incubated with appropriate primary and secondary antibody after blocking. Secondary antibody coupled with horseradish peroxidase was detected by an ECL system (Amersham Biosciences).
shRNA/siRNA
Oligonucleotides for shRNA construction were designed using an shRNA sequence design tool (Applied Biosystems/Ambion, Austin, TX, USA). The target sequences for chchd2 were as follows: 5Ј-AAGCCGAAGCCGCACTTCCCG-3Ј corresponding to nucleotides 12-32 of the coding region. The scrambled sequences (5Ј-GCCGCACAAGCCGAACCGTTC-3Ј) corresponding to the same region were used as a control. The shRNA against chchd2 or scrambled sequences was cloned into the shRNA expression vector pU6shx to generate pU6shx/chchd2 or pU6shx/chchd2 SC, respectively. Plasmid pU6shx/chchd2 SC with the scrambled sequence produces a nonspecific RNA. HABP1 siRNA (sc-42881) and control siRNA (sc-37007) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
RT-PCR
Total RNA was extracted from NIH3T3 fibroblast cells using TRIzol reagents (Molecular Research Center Inc.; Cincinnati, OH, USA). Reverse transcription was performed using Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI, USA) and oligo(dT) primer. PCR amplification using primer sets specific for mouse chchd2, mouse HABP1, ⌿ signal, and neomycin-resistance cassette (Neo) was carried out at 55°C annealing temperature for 25 cycles. PCR for ␤-actin was performed at 55°C annealing temperature for 20 cycles. Nucleotide sequences of the primers were based on published cDNA sequences of mouse chchd2, mouse HABP1, Neo, ⌿ signal, and ␤-actin: chchd2 forward, ATGGCCCAGATGGCTACC, and chchd2 reverse, CTGGTTCTGAGCACACTCCA; HABP1 forward, GGCCTTCGTTGAATTCTTGA, and HABP1 reverse, TC-CGCAAGGAAATCCATTAG; Neo forward, TTGCTCCTGC-CGAGAAAG, and Neo reverse, CAATATCACGGGTAGCCAAC; ⌿ signal forward, GTCTGTCCGATTGTCTAGTGT, and ⌿ signal reverse, AGGTTCTCGTCTCCTACCAGA; and ␤-actin forward, ATCCTGAAAGACCTCTATGC, and ␤-actin reverse, AACGCAGCTCAGTAACAGTC. ␤-Actin was used as an internal control to evaluate relative expression of chchd2.
Immunofluorescence microscopy
Immunofluorescence analysis was performed as described previously (16) . In brief, NIH3T3 fibroblast cells (1ϫ10 4 cells/well in 24-well plates) were cultured on sterile coverslips. After incubation for 24 h, the cells were fixed with 4% paraformaldehyde in PBS for 30 min and washed twice with 0.02% Tween 20 in PBS (5-10 min each). Samples were blocked with 1% BSA in PBS for 10 min. The blocked cells were then incubated with c-Myc tag, FLAG tag, and vinculin antibodies or TRITC-conjugated phalloidin for 1 h at room temperature. After washing 3 times (5-10 min each) with 0.02% Tween 20 in PBS, cells were incubated with FITC-conjugated secondary antibody (antimouse IgG, 1:1000) or Cy5-conjugated secondary antibody (antirabbit IgG, 1:1000) for 60 min at room temperature. Finally, samples were washed 3 times with 0.02% Tween 20 in PBS (5-10 min each) and incubated with 2.5 g/ml Hoechst 33342 fluorochrome (Invitrogen) or 0.1 g/ml 4Ј,6Ј-diamidino-2-phenylindole (DAPI) (Millipore). The coverslips with cells were dried in a 37°C oven for 45 min and mounted in a 1:1 mixture of xylene and malinol and then were examined under a fluorescence microscope (Axioplan2; Carl Zeiss; Jena, Germany) or confocal microscope (LSM510; Carl Zeiss).
RhoA activation assay
Rho-GTP levels were measured by a pulldown assay using glutathione S-transferase (GST) fused to the Rho-binding domain of rhotekin (GST-RBD) (Pierce, Rockford, IL, USA), whereas Rac-GTP and Cdc42-GTP levels were measured using GST fused to the p21 binding domain of p21-activated kinase-1 (GST-PBD) (Millipore). Cells were lysed and incubated with GST-RBD or GST-PBD for 45 min at 4°C, washed 3 times, and resolved by SDS-PAGE. The mouse anti-RhoA, Rac1, and Cdc42 antibodies were purchased from Cytoskeleton. For the ELISAbased RhoA activation assays, a RhoA G-LISA Activation Assay kit (Cytoskeleton, Inc.) was used, and the procedure recommended by the manufacturer was followed. In brief, samples were lysed and centrifuged at 13,000 rpm for 15 min at 4°C. The supernatant containing 37 g of proteins was transferred into a plate, and equal volumes of ice-cold binding buffer mixtures were added into each well. The plate was shaken on a cold orbital microplate shaker (300 rpm) for 30 min at 4°C, flicked out of the solution from wells, and sequentially incubated with diluted anti-RhoA primary antibodies and secondary antibodies on a microplate shaker (300 rpm) at room temperature. The plate was incubated with a horseradish peroxidase detection reagent for 15 min at 37°C. After addition of the horseradish peroxidase stop buffer, the absorbance was immediately recorded at 490 nm.
Immunoprecipitation
Cells were lysed in triple-detergent lysis buffer (50 mM Tris-HCl, pH 8.0; 150 mM NaCl; 0.02% sodium azide; 0.1% SDS; 1% Nonidet P-40; 0.5% sodium deoxycholate; and 1 mM phenylmethyl sulfonyl fluoride). The lysates were centrifuged for 20 min at 4°C, and the supernatants were collected. Protein concentration in cell lysates was determined using a Quant-iT Protein Assay kit. To remove nonspecific binding proteins in the lysates, the samples were incubated with an ϳ30-l packed volume of recombinant protein G-agarose (PGA) for 1 h at 4°C. After a brief centrifugation, supernatants were collected and then incubated with 1 g/ml Myc or FLAG tag antibody for 4 h at 4°C. PGA (30 l) was then added and incubated for 4 h. Afterward, Myc-Ab-PGA or FLAG-Ab-PGA complexes were washed 3 times with wash buffer (50 mM HEPES, 150 mM NaCl, 0.1% Triton X-100, and 10% glycerol), and a sample buffer (20% glycerol, 6% SDS, and 10% 2-mercaptoethanol) was added. The samples were boiled for 5 min and centrifuged. Supernatants were subjected to SDS-PAGE (10% gel) followed by Western blot analysis.
separated by electrophoresis on 10% polyacrylamide gel and visualized by silver staining. The protein band of interest was excised from silver-stained gel for in-gel tryptic digestion. The excised gel slices were destained and shrunk by dehydration in acetonitrile and dried in a vacuum centrifuge. Proteins within shrunk gel slices were then digested overnight with trypsin at a substrate/enzyme ratio of 10:1 (wt/wt) in 25 mM ammonium bicarbonate (pH 8.0). The enzyme reaction was terminated by addition of 0.1% formic acid in water. Peptides from gel pieces were extracted by sonication for 10 min, and supernatants containing peptides were transferred to new tubes. Peptides were analyzed using a liquid chromatography (LC) and tandem mass spectrometry (MS/MS) system with reverse-phase LC, which was composed of a Surveyor MS pump (Thermo Electron, San Jose, CA, USA), a Spark autosampler (Spark Holland, Emmen, The Netherlands), and a Finnigan LTQ linear ion-trap mass spectrometer (Thermo Electron) equipped with nanospray ionization sources. All MS/MS data were searched against the IPI mouse protein database (version 3.16) using the SEQUEST algorithm (Thermo Electron) incorporated into BioWorks software (version 3.2).
Statistical analysis
All data are presented as means Ϯ sd from Ն3 independent experiments. Statistical comparison between different treatments was done by either Student's t test or 1-way ANOVA after Student-Newman-Keuls post hoc analysis using SPSS 12 (SPSS Inc., Chicago, IL, USA). A value of P Ͻ 0.05 was considered statistically significant.
RESULTS

Isolation of cell migration-promoting genes
To identify novel cell migration-promoting genes, NIH3T3 fibroblast cells were infected with a retroviral mouse brain cDNA library at MOI of 1. Two days after infection, cells were seeded onto the upper face of the transwell culture inserts (top compartment in Fig. 1 ) Figure 1 . Schematic illustration of novel gain-offunction in vitro selection for the cell migrationpromoting genes. Production and infection of retroviral cDNA library was described in Materials and Methods. Two days after infection, cells were seeded (4ϫ10 4 cells/well) onto the transwell culture inserts and incubated at 37°C for 5 h. Migrated cells were obtained by detachment from the lower face of the transwell culture inserts and reseeded onto the transwell culture inserts, which were then allowed to migrate again for enrichment (5 times). After the final round of enrichment, migrated cells were expanded into individual clones through the limiting dilution. The chromosomally integrated cDNAs were identified by PCR followed by sequencing. Finally, identified cDNA fragments were cloned into pcDNA3 and further analyzed. and allowed to migrate through the membrane to the lower face of the transwell culture inserts (bottom compartment in Fig. 1 ) for 5 h. Migrated cells were isolated by detaching them from lower face of the transwell culture inserts or bottom of the culture well. Detached cells were reseeded onto the upper face of the transwell culture inserts, which were then allowed to migrate through the membrane again for enrichment. This process was repeated 5 times. After the final round of enrichment, migrated cells were expanded into 50 individual clones through the limiting dilution, from which genomic DNA was extracted. Chromosomally integrated library cDNAs were PCR-amplified using specific primers and identified by sequence determination. DNA sequencing revealed that 10% of the cDNAs identified had been reported previously to be related to cell migration. The remaining cDNA clones included genes without a previous implication in cell migration or partial cDNAs that were thought to be a false-positive result. Among the 50 cDNAs identified, the 13 clones shown in Table 1 were selected for further investigation. Cell migration activity of the 13 cDNAs was individually tested by transient expression in NIH3T3 fibroblast cells. The cDNAs were cloned into pcDNA3 and then transiently transfected into NIH3T3 fibroblast cells or HEK293 epithelial cells. Expression of the transiently transfected cDNAs was confirmed by RT-PCR of the neo sequence of pcDNA3 (Fig. 2) . Subsequently, migration activity of transfectants was assessed by a 3-dimensional cell migration assay using transwell culture inserts ( Fig. 2 ; Table 1 ).
Among the cDNAs tested, cytohesin-2 (cyth2) most strongly increased cell migration activity of NIH3T3 fibroblast cells and HEK293 epithelial cells. Cytohesin-2 has been previously associated with cell migration and has been reported to activate ARF6 to regulate actin reorganization and membrane ruffling (18, 19) . ARF6 is known to regulate cell migration (18, 20) and controls peripheral membrane dynamics and actin rearrangements at the plasma membrane (21, 22) , such as stress fiber disassembly (23, 24) and formation of plasma membrane protrusions and ruffles (23, 25, 26) . Actin-related protein 2/3 complex subunit 3 (Arpc3) and neurensin-1 (nrsn-1) also increased migration of NIH3T3 fibroblast cells in the transwell culture insert assays (153Ϯ14 and 141Ϯ12%, respectively, in comparison with the vector control). Arpc3 was previously involved in podia formation (27) and membrane protrusion (28) . Neurensin-1 is a neuronspecific membranous protein that plays an essential role in neurite extension (29) . Our screen identified many genes that have been previously associated with cell migration and protrusion. Many cytoskeleton-related genes were also identified, therefore confirming the validity of the screen method. The 13 genes were also subjected to network analysis using MetaCore software (GeneGo Inc., St. Joseph, MI, USA). Eight genes were found in their database, and they formed a cross-interaction network. In particular, Arpc3 and Myl6 were included in a canonical pathway map of cell migration and adhesion, giving further credence to the screen strategy used (Supplemental Fig. S3 ).
Chchd2 was identified as a novel cell migration determinant in this study; it increased cell migration activity by 163 Ϯ 12% compared with that in control cells (Table 1) . CHCHD2 protein is a member of a protein family that has the (coiled coil 1)-(helix 1)-(coiled-coil 2)-(helix 2) domain (CHCH domain). The first and second coiled coil region of the CHCH domain has a fixed length of 10 aa and a variable length of 5-10 aa, respectively. The second coiled coil region may act as a bridge when the two helices fold toward each other. Each ␣-helix within the CHCH domain contains 2 cysteine amino acids, which are separated by 9 amino acids (C-X9-C motif). Two interhelical disulfide bonds may contribute to the formation of the hairpin structure (30) . However, functional significance of the CHCH domain or CHCHD2 is not clearly understood. Proteins containing this CHCH domain include ethanol-induced protein 6 (Etohi6), estrogen-induced gene 2 (E2IG2), Mrp10p, mature T cell proliferation-1 type A (p8MTCP1), CHCH domain-containing protein 3 (ChChd3), and C2360. The Etohi6 and E2IG2 proteins have been shown to respond to ethanol (31) and estrogen (32) , respectively. The Mrp10p protein has been described as a mitochondrial ribosomal protein (33) . The p8MTCP1 protein is a putative oncogene that is expressed in T cell prolymphocytic leukemia with t(X;14) transloca- tions (34 -37) (38) . The C2360 is strongly expressed during early extraembryonic development, as in the first trimester placenta and JEG3 choriocarcinoma cells. C2360 is also expressed in human embryonic stem cells; in contrast, all adult tissues showed no detectable expression of the transcript (30) . CHCH domain-containing proteins have been reported to localize in a nucleus or mitochondrial compartment (30, 38 -40) .
Chchd2 promotes cell migration
To further investigate the role of chchd2 in cellular migration, the GFP-fused chchd2 was introduced into NIH3T3 fibroblast cells to generate a cell line that stably expresses chchd2 (NIH3T3/chchd2-GFP) (Fig. 3A) . GFP was fused to the C terminus of chchd2. The cell migration-promoting activity of chchd2 was then assessed by a wound-healing assay and transwell culture inserts assay. The confluent monolayer of NIH3T3/chchd2-GFP, NIH3T3/GFP, and parental NIH3T3 fibroblast cells was scratch-wounded with sterile pipette tips and incubated for 48 h. The wound healing of NIH3T3/chchd2-GFP cells was 64% at 24 h after wounding, which was 1.65 times higher than that of NIH3T3/GFP cells (Fig. 3B) . Fortyeight hours after wounding, NIH3T3/chchd2-GFP cells became confluent; however, the percentage of wound closure of NIH3T3/GFP and NIH3T3 fibroblast cells was only 62 and 78%, respectively. A similar migrationpromoting activity of chchd2 was found in the transwell (Fig. 3C) , indicating that chchd2 promoted the migratory ability of NIH3T3 fibroblast cells in both 2-and 3-dimensional cell migration assays. Cell migration-promoting activity of chchd2 was also tested in HEK293 human epithelial cells. A similar result was obtained in HEK293 cells transfected with chchd2-GFP (Supplemental Fig. S4 ). We next sought to determine whether knockdown of the endogenous chchd2 expression would impair cell migration (Fig. 4) . The shRNA-mediated knockdown of chchd2 expression was confirmed by RT-PCR analysis (Fig. 4A) . NIH3T3 fibroblast cells transfected with chchd2 shRNA showed significantly reduced motility compared with cells transfected with control shRNA of a scrambled sequence (Fig.  4B) . We also performed a wound-healing assay to monitor the effects of chchd2 knockdown on cell migration and obtained similar results; knockdown of chchd2 expression caused a delay in wound closure (data not shown). Taken together, these results indicate that chchd2 plays a key role in cell motility.
Intracellular localization of CHCHD2 and its functional domain analysis
Having shown that chchd2 promotes cell migration, we next attempted to determine the intracellular localization and functional domain of the CHCHD2 protein. For this purpose, GFP-fused full-length or N-/C-terminal truncation constructs of the coding region of CHCHD2 were generated. Because the CHCH domain is in the Cterminal half of the protein, the full-length protein was split into two fragments to produce N-or C-terminal truncation constructs. A point mutant construct of CHCHD2 was also generated, because CHCHD2 has a predicted phosphorylation site at the Ser-45 residue (39). This serine residue was switched to alanine in the fulllength CHCHD2 protein by site-directed mutagenesis to generate a phosphorylation site-defective protein (CHCHD2 S45A ). When transiently expressed in NIH3T3 fibroblast cells, the CHCHD2-GFP protein of full-length, C-terminal truncated form (CHCHD2 ⌬101-153 ) and CHCHD2 S45A showed nuclear localization with a minor expression in cytoplasm (Fig. 5A) . However, the CHCHD2-GFP fusion protein with N-terminal truncation (CHCHD2
⌬1-70
) showed a localization pattern similar to that of GFP, which was found in the nucleus as well as in cytoplasm. These results indicate that CHCHD2 is mainly localized in the nucleus, and a putative nuclear localization signal may reside in the N-terminal half of the protein, further suggesting that the C-terminal region of the protein containing CHCH domain may not be important for its nuclear localization. To explore the possibility that CHCHD2 may have transcription activation potential, CHCHD2 was fused to the DNAbinding domain of GAL4 and tested for activity as a transcriptional activator in yeast, which was analogous to the yeast 1-hybrid system. CHCHD2 did not exhibit any effect on the reporter gene expression, arguing against the role of CHCHD2 as a transcriptional activator in the nucleus (Supplemental Fig. S5 ). In the next set of experiments, CHCHD2 ⌬ 1 -7 0 , CHCHD2 ⌬ 1 0 1 -1 5 3 , and CHCHD2 S45A constructs were subjected to a cell migration assay to determine the role of the each domain in cell migration. As shown in Fig. 5B , N-or C-terminal truncation of CHCHD2 completely abrogated the cell migration-promoting activity of the protein. However, the point mutation at serine (S45A) did not affect cell motility. These findings indicate that both N-and C-terminal regions, but not the predicted phosphorylation site, are necessary for cell migration-promoting activity of CHCHD2. The results also indicate that the CHCH domain alone is not sufficient for cell migration activity. The role of the CHCH domain in cell migration is not conclusive at present.
Chchd2 modulates distribution of focal adhesion and organization of actin stress fibers through RhoA
Several studies suggested the critical function of the cytoskeleton in cellular motility (41) (42) (43) (44) . Thus, we examined the distribution of focal adhesion and actin stress fibers in the chchd2-overexpressed cells. Formation of actin stress fibers was increased in chchd2-GFP-overexpressed cells in comparison with GFP-transfected control cells (Fig. 6A) . In addition, chchd2-GFP-overexpressed cells showed a modest increase in the distribution of vinculin at the focal adhesion in comparison with GFPexpressed control cells (Fig. 6B, C) . Western blot analysis revealed no changes in vinculin or actin levels in chchd2-GFP-overexpressed cells, suggesting that the forced expression of chchd2 did not affect vinculin or actin expression levels (Fig. 6D) . We also assessed whether knockdown of endogenous chchd2 expression would regulate focal adhesion and actin cytoskeleton organization. The chchd2 knockdown by specific shRNA decreased the distribution of focal adhesion and actin cytoskeleton organization compared with cells transfected with the scrambled shRNA sequence (data not shown). When cells migrate, RhoA is activated not only at the tail but also at the leading part of migrating cells (45) (46) (47) . In addition, the Rho/ROCK signaling pathway is involved in the organization of the actin cytoskeleton and cell migration (48 -51) . Because chchd2 promoted cell migration, we examined whether chchd2 enhances RhoA activity. When chchd2-GFP was introduced, the amount of active RhoA was increased ϳ1.3 times compared with that in GFPexpressed control cells (Fig. 7A, B) . However, the levels of active Rac1 or Cdc42 were not affected (data not shown). Although the increase in RhoA activity was modest, it was observed in two independent assays that measured RhoA activity: the pulldown assay and the ELISA. Pharmacological inhibitors of RhoA or ROCK were next used to further examine the role of the RhoA pathway in chchd2 actions. Chchd2-induced cell migration was almost com- pletely blocked by inhibition of Rho/ROCK signaling (Fig. 7C, D) . The cell-permeable C3 transferase is an ADP-ribosyltransferase of Clostridium botulinum that specially inhibits RhoA. Y27632 is a specific inhibitor of Rho-associated kinase (ROCK) (50, 52) . Both inhibitors suppressed chchd2-induced cell migration.
Role of Akt and Jnk pathways in chchd2-induced cell migration
Phosphatidylinositol 3-kinase (PI3K)/Akt signaling has been associated with cell migration. PI3K/Akt enhanced actin remodeling and generated membrane protrusions (53) . It also induced cell migration and cell invasion through remodeling of the actin cytoskeleton (54) . Mitogen-activated protein kinase family members participate in universal signaling cascades that exert an enormous range of effects on multiple cell types. In particular, Jnk signaling has been reported to play an important role in cellular functions such as apoptosis, proliferation, and migration (55) (56) (57) (58) (59) (60) . Recent studies indicate that activation of Rho/ROCK is (critically) involved in cell proliferation and migration of vascular smooth-muscle cells through Jnk activation (61, 62) . To determine whether the Akt and Jnk signaling pathways are involved in chchd2-promoted cell migration, the activation of Akt and Jnk in chchd2- Figure 5 . Structural domain analysis of CHCHD2 protein. NIH3T3 fibroblast cells were stably transfected with various mutant constructs of chchd2: a point mutation, N-terminal, or C-terminal truncated form of chchd2; GFP, pEGFP-N1 (Clontech Laboratories Inc., Palo Alto, CA, USA); chchd2-wild-type-GFP, GFP-fused wild-type chchd2; chchd2-S45A-GFP, GFP-fused chchd2 with alanine instead of serine at residue 45; chchd2
⌬101-153
-GFP, GFP-fused chchd2 with C-terminal deletion of residues 101-153; and chchd2
⌬1-70 -GFP, GFP-fused chchd2 with N-terminal deletion of residues 1-70. A) For the determination of intracellular localization of the chchd2 mutant constructs, transfected NIH3T3 fibroblast cells were plated on coverslips and incubated at 37°C for 24 h. After fixation, cells were visualized by confocal microscopy. Images were taken at ϫ200. Left panel: representative microscopic images. Right panel: schematic diagram of the mutant constructs. B) Expression of introduced constructs in the transfectants was confirmed by Western blot (WB) analysis (top panel). Subsequently, cell migration activity was evaluated using the transwell culture inserts as described above (bottom panel). Values are means Ϯ sd (nϭ3). *P Ͻ 0.01 vs. control GFP vector transfectants. Figure 6 . Chchd2 regulations of actin stress fibers and focal adhesion. A, B) NIH3T3 fibroblast cells stably transfected with GFP or chchd2-GFP constructs were plated on coverslips and incubated at 37°C for 24 h. Cells were then fixed and stained with rhodamine-labeled phalloidin for the detection of stress fibers (A) or vinculin antibody for the detection of focal adhesion (B). Cy5-conjugated secondary antibody was used for the vinculin detection. Images were taken by confocal microscopy at ϫ200. Cells were also examined for DAPI staining and GFP fluorescence. SF, stress fiber. C) Relative fluorescence intensity of stress fiber (left) and vinculin (right) was quantified with LSM 5 Exciter 4.2 software (Carl Zeiss). *P Ͻ 0.01 vs. control GFP vector transfectants. D) Western blot analysis was performed to detect the expression of GFP, vinculin, and ␤-actin in GFP-or chchd2-GFP-overexpressed NIH3T3 fibroblast cells. expressed NIH3T3 fibroblast cells was examined. As shown in Fig. 8 , the levels of phospho-Akt and phosphoJnk were increased in NIH3T3 fibroblast cells that were either transiently or stably transfected with chchd2. Moreover, specific inhibition of Akt or Jnk significantly reduced chchd2-induced cell migration. Specific inhibition of Akt also reduced RhoA activity (Supplemental Fig. S6 ). These results suggest that chchd2 promotes cell migration through the Akt-RhoA-ROCK-Jnk pathway.
CHCHD2 interacts with HABP1
In an attempt to gain a better understanding of chchd2-induced cell migration, CHCHD2-interacting proteins were identified by coimmunoprecipitation followed by LC-MS/MS analysis. For this purpose, a c-Myc-tagged chchd2 was constructed, which was then transfected into NIH3T3 fibroblast cells followed by immunoprecipitation using the anti-Myc antibody. The proteins coimmunoprecipitated with Myc-tagged CHCHD2 were separated by SDS-PAGE and visualized by silver staining, which was then identified using LC-MS/MS analysis. As shown in Fig. 9B , a major protein was coimmunoprecipitated with Myc-CHCHD2, and it was identified as HABP1 ( Table 2) . Next, the interaction between CHCHD2 and HABP1 was confirmed by immunoprecipitation and Western blot analysis. NIH3T3 fibroblast cells were cotransfected with Myc-tagged chchd2 and FLAG-tagged HABP1. Empty vector-transfected NIH3T3 fibroblast cells were used as a control. Transfected cells were lysed and immunoprecipitated with either anti-Myc or anti-FLAG antibody, and subjected to Western blot detection of CHCHD2 or HABP1, respectively. This experiment verified that CHCHD2 and HABP1 were coimmunoprecipitated, thereby interacting with each other in vivo (Fig. 9C) . To obtain further evidence of interaction between CHCHD2 and HABP1, the possibility of colocalization of the two proteins was explored by performing immunocytochemical staining of NIH3T3 fibroblast cells that coexpressed Myc-tagged CHCHD2 and FLAG-tagged HABP1. Unexpectedly, immunostaining revealed that CHCHD2 and HABP1 were colocalized in the cytosolic compartment of NIH3T3 fibroblast cells (Fig. 9D) . When transfected alone, CHCHD2 and HABP1 showed mostly nuclear and cytosolic localization, respectively (Figs. 5 and 9 and Supplemental Fig. S7 ). However, when these two proteins were coexpressed, both proteins were localized in cytoplasm. The results indicated that overexpression of HABP1 induced translocation of nuclear CHCHD2 to the cytosolic compartment, which might be caused by physical interaction between these two proteins.
Opposing effects of chchd2 and HABP1 on cell migration
To determine the role of CHCHD2-HABP1 interaction in cell migration, NIH3T3 fibroblast cells transfected with chchd2 and HABP1 either alone or in combination were subjected to a cell migration assay. The transwell culture insert assay revealed that HABP1 transfection reduced the migratory activity of NIH3T3 fibroblast cells compared with an empty vector transfectant and completely abolished chchd2-promoted cell migration (Fig. 10B) . Similar results were obtained in the wound-healing assay (data not shown). RhoA activity correlated with cell migration phenotype. Introduction of exogenous HABP1 downregulated basal activity of RhoA and abrogated the chchd2-induced increase in RhoA activity (Fig. 10C) . Taken together, these results provide evidence that chchd2 and HABP1 exert opposing effects on cell migration through reciprocal regulation of RhoA activity. We next performed simultaneous knockdown of both HABP1 and chchd2. NIH3T3 fibroblast cells transfected with chchd2 shRNA and HABP1 siRNA either alone or in combination were subjected to a cell migration assay. The knockdown of the endogenous HABP1 expression slightly increased cell migration; however, it did not further modulate the effects of chchd2 knockdown (Supplemental Fig. S8B ). The siRNA/shRNA-mediated knockdown of HABP1 or chchd2 was confirmed by RT-PCR analysis (Supplemental Fig. S8A ).
DISCUSSION
In vitro and in vivo functional genetic screening is a powerful tool used for the identification of genes that contribute to a phenotype of interest, such as cell proliferation (5), protein transport (8), protein phosphorylation (7), gene transcription (6, 63) , tumor suppression (64), apoptosis (9), metastasis (13) , and bacterial virulence (65) . In this study, we designed a functional genetic screening strategy for in vitro selection of novel cell migration-promoting determinants. The retrovirus was used as a gene transfer tool, because retrovirus systems exhibit high transduction efficiency and enable long-term expression of desired transgenes and resulting phenotypes (10, 12) . Using this method, it was possible to successfully isolate genes with the desired phenotype. Many genes selected by the screen were previously involved in cell migration, therefore giving credence to the proposed method.
Chchd2 was one of the novel cell migration determinants identified in this study. CHCHD2 protein contains a CHCH domain in the C-terminal region and a potential phosphorylation residue at Ser-45 (39) . However, cellular functions of CHCHD2 protein, CHCH domain, or the potential phosphorylation site have not been characterized yet. This is the first work that linked CHCHD2 protein to cellular migration. Overexpression of chchd2 promoted cell migration; however, knockdown of the endogenous chchd2 reduced cell motility. Functional domain analysis revealed that the CHCH domain alone did not exert cell migrationstimulating activity and the phosphorylation residue was not necessary for the activity. Previously, human chchd2 was determined by transcriptome analysis to be one of the genes whose expression was increased in some of cancer tissues compared with normal tissues (66, 67) , suggesting that chchd2 may be related to progression of cancer, such as tissue invasion and metastasis. The cell migration-promoting activity of chchd2 supports this possibility. However, cell proliferation was not significantly affected by chchd2 (unpublished results).
This study demonstrated that CHCHD2 interacts with HABP1 in NIH3T3 fibroblast cells (Fig. 9) , and these two proteins have opposing effects on cell migration and RhoA activity (Fig. 10) . HABP1 is a multifunctional protein, whose N-terminal ␣-helix is essential for its protein-protein interaction, and HABP1 is involved were harvested 2 d after transfection, and cell extracts were prepared for 10% SDS-PAGE. Separated proteins were silver stained, and coimmunoprecipitated proteins with anti-Myc tag antibody were identified by LC-MS/MS. C) NIH3T3 fibroblast cells stably cotransfected with FLAG-tagged HABP1 and Myc-tagged chchd2 constructs were immunoprecipitated with anti-Myc or -FLAG tag antibodies as indicated. Top panel: immunoprecipitates were run on SDS-PAGE and analyzed for the expression of the tagged proteins by Western blot analysis. Immunoprecipitation with recombinant PGA alone without either Myc or FLAG antibody was used as a control, where no specific band was detected (data not shown). Bottom panel: schematic diagram of the Myc-tagged chchd2 or FLAG-tagged HABP1 constructs. D) NIH3T3 fibroblast cells cotransfected with FLAG-tagged HABP1 and Myc-tagged chchd2 constructs were plated on coverslips for 24 h, fixed, and stained with FITC-conjugated secondary antibody to visualize Myc-tagged CHCHD2 or Cy5-conjugated secondary antibody to visualize FLAG-tagged HABP1, respectively. Nuclei were stained with DAPI. IP, immunoprecipitation; WB, Western blot. in diverse cellular processes (68 -70) . HABP1 has been reported to localize to all major subcellular compartments, including mitochondria (71, 72) , nucleus, and cytoplasm (73, 74) . The protein has also been detected on the cell surface (75) (76) (77) and secreted into the extracellular matrix (78, 79) . A few recent reports have shown that mitochondrial/cell surface HABP1/P32 is involved in tumor progression (80) and induction of apoptosis (81, 82) . In addition, HABP1 interacts specifically with HA, which has been implicated in cell adhesion, tumor invasion/metastasis (84, 84) , sperm maturity and motility (85 86) , and cellular signaling (87) . Studies in animal models have documented a crucial role for HA in tumor growth and metastasis (88, 89) . Inhibition of endogenous HA synthesis dramatically reduced tumor growth in vivo (90). The expression level of HABP1 was reduced in metastasized tumor, leading to disruption of its interaction with HA, implying a role in the regulation of tumor metastasis (91) . These previous reports are in agreement with the cell migration-inhibiting effects of HABP1 observed in the current study. Although HABP1 was first named after its interaction with HA, this protein has also been identified as the p32 subunit of precursor mRNA splicing factor SF2, as well as C1q globular domainbinding protein. Thus, HABP1 may influence cell migration independently of HA. We propose a hypothetical model of functional roles of CHCHD2 and HABP1 in cell migration (Fig. 11) . In the proposed model, CHCHD2 may not only act as an activator of Akt, RhoA/ROCK, and Jnk signaling but may also interact with HABP1. CHCHD2 may stimulate cell migration via the following cascade of events: 1) CHCHD2 activates Akt phosphorylation, which in turn leads to RhoA activation; 2) activation of the RhoA/ROCK pathway enhances Jnk phosphorylation and actin polymerization; and 3) activation of Jnk induces formation of focal adhesion. Concurrently, CHCHD2-induced cell migration may be subject to down-regulation by physical interaction with HABP1. When the HABP1 level is low, Figure 10 . Opposite effects of HABP1 and CHCHD2 on cell migration. A) After stable transfection of NIH3T3 fibroblast cells with Myc-tagged chchd2 and FLAG-tagged HABP1 either alone or in combination, expression of the constructs was confirmed by Western blot analysis using antibodies against Myc or FLAG tag. B) Stably transfected cells (4ϫ10 4 cells/well) were seeded onto culture inserts and incubated at 37°C for 5 h. Migrated cells were stained and counted in 5 randomly selected fields of 3 independent experiments. C) Similarly, transfected cells were lysed, and RhoA activity was measured by using a RhoA G-LISA Activation Assay kit. Results are means Ϯ sd (nϭ3). *P Ͻ 0.01. the majority of CHCHD2 resides in the nucleus and stimulates the Akt/Rho/ROCK/Jnk pathway to promote cell migration (Supplemental Fig. S9A ). In contrast, an increase in the cellular level of HABP1 may trap CHCHD2 in the cytosol, interfering with the cell migration-promoting activity of CHCHD2 (Supplemental Fig. S9B ). This speculation is only based on colocalization of overexpressed CHCHD2/HABP1 and opposite effects of these two proteins on cell migration when overexpressed. The model of reciprocal regulation of cell migration by CHCHD2 and HABP1 needs to be further tested by gene ablation, knockdown, or endogenous protein interaction. In addition, it is not known how nuclear CHCHD2 initiates the Akt/Rho/ROCK/ Jnk pathway. Our conclusion is based on a Rho activity assay in chchd2-overexpressed cells and various pharmacological inhibitors of Rho and other potential downstream signaling components, which certainly have limitations. The relationship between chchd2 and Rho signaling needs to be corroborated by further mechanistic studies. Nonetheless, involvement of the Akt/Rho/ROCK/Jnk pathway in controlling actin dynamics and cell migration is supported by ample evidence. PI3K/Akt signaling induces remodeling of the actin cytoskeleton, leading to cell migration, and it also activates RhoA (13, 54, 92) . The Rho/ROCK signaling pathway is involved in the organization of the actin cytoskeleton and cell migration (48, 50) . The Jnk pathway has been implicated in the regulation of cell migration through the cytoskeleton reorganization (57, 93) . These findings support the assumption that CHCHD2 induces cell migration by controlling actin dynamics through Akt-Rho-Jnk signaling.
CONCLUSIONS
Our in vitro selection strategy successfully identified cell migration-promoting genes. CHCHD2 was one of the novel cell migration-promoting proteins that were identified by the screen. CHCHD2 appeared to increase the degree of cell motility through the activation of the Akt-Rho-ROCK-Jnk pathway, followed by reorganization of the actin cytoskeleton and focal adhesion. Furthermore, CHCHD2 interacted with HABP1 to reciprocally regulate cell migration. However, these results are not conclusive as to how CHCHD2 may work to regulate migration and what might be the physiological function of an association with HABP1. Further studies are necessary to gain a better understanding of the role of CHCHD2, its downstream events, and interacting proteins in cell migration. Cell migration occurs by a multistep process requiring the coordinated action of many genes. Cell migration remains a poorly understood process in cell biology despite extensive study. It is suggested that our in vitro genetic selection method may assist in the systematic identification and characterization of additional genes that are involved in cell migration, thus advancing our understanding of the cell migration process and ultimately providing new therapeutic targets for the treatment of cancer invasion/metastasis, inflammatory disease, angiogenesis, and regeneration of injured tissue, where cell migration is commonly involved in the pathophysiology. Finally, the genetic selection method described here can also be applied to other assay systems in which cells with a desired phenotype can be physically separated.
